DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies

Abstract

Abstract The use of bispecific antibodies (BsAbs) to treat human diseases is on the rise. Increasingly complex and powerful therapeutic mechanisms made possible by BsAbs are spurring innovation of novel BsAb formats and methods for their production. The long‐lived in vivo pharmacokinetics, optimal biophysical properties and potential effector functions of natural IgG monoclonal (and monospecific) antibodies has resulted in a push to generate fully IgG BsAb formats with the same quaternary structure as monoclonal IgGs. The production of fully IgG BsAbs is challenging because of the highly heterogeneous pairing of heavy chains (HCs) and light chains (LCs) when produced in mammalian cells with two IgG HCs and two LCs. A solution to the HC heterodimerization aspect of IgG BsAb production was first discovered two decades ago; however, addressing the LC mispairing issue has remained intractable until recently. Here, we use computational and rational engineering to develop novel designs to the HC/LC pairing issue, and particularly for κ LCs. Crystal structures of these designs highlight the interactions that provide HC/LC specificity. We produce and characterize multiple fully IgG BsAbs using these novel designs. We demonstrate the importance of specificity engineering in both the variable and constant domains to achieve robust HC/LCmore » specificity within all the BsAbs. These solutions facilitate the production of fully IgG BsAbs for clinical use.« less

Authors:
 [1];  [2];  [1];  [1];  [1];  [1];  [1];  [1];  [2];  [1];  [1];  [1];  [3];  [1]
  1. Eli Lilly Biotechnology Center, 10300 Campus Point Drive San Diego California 92121
  2. Department of Biochemistry and Biophysics University of North Carolina at Chapel Hill Chapel Hill North Carolina
  3. Department of Biochemistry and Biophysics University of North Carolina at Chapel Hill Chapel Hill North Carolina, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Chapel Hill North Carolina
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1393306
Grant/Contract Number:  
DE‐AC02‐06CH11357
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
Protein Science
Additional Journal Information:
Journal Name: Protein Science Journal Volume: 26 Journal Issue: 10; Journal ID: ISSN 0961-8368
Publisher:
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Froning, K. J., Leaver‐Fay, A., Wu, X., Phan, S., Gao, L., Huang, F., Pustilnik, A., Bacica, M., Houlihan, K., Chai, Q., Fitchett, J. R., Hendle, J., Kuhlman, B., and Demarest, S. J. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies. United Kingdom: N. p., 2017. Web. doi:10.1002/pro.3240.
Froning, K. J., Leaver‐Fay, A., Wu, X., Phan, S., Gao, L., Huang, F., Pustilnik, A., Bacica, M., Houlihan, K., Chai, Q., Fitchett, J. R., Hendle, J., Kuhlman, B., & Demarest, S. J. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies. United Kingdom. https://doi.org/10.1002/pro.3240
Froning, K. J., Leaver‐Fay, A., Wu, X., Phan, S., Gao, L., Huang, F., Pustilnik, A., Bacica, M., Houlihan, K., Chai, Q., Fitchett, J. R., Hendle, J., Kuhlman, B., and Demarest, S. J. Mon . "Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies". United Kingdom. https://doi.org/10.1002/pro.3240.
@article{osti_1393306,
title = {Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies},
author = {Froning, K. J. and Leaver‐Fay, A. and Wu, X. and Phan, S. and Gao, L. and Huang, F. and Pustilnik, A. and Bacica, M. and Houlihan, K. and Chai, Q. and Fitchett, J. R. and Hendle, J. and Kuhlman, B. and Demarest, S. J.},
abstractNote = {Abstract The use of bispecific antibodies (BsAbs) to treat human diseases is on the rise. Increasingly complex and powerful therapeutic mechanisms made possible by BsAbs are spurring innovation of novel BsAb formats and methods for their production. The long‐lived in vivo pharmacokinetics, optimal biophysical properties and potential effector functions of natural IgG monoclonal (and monospecific) antibodies has resulted in a push to generate fully IgG BsAb formats with the same quaternary structure as monoclonal IgGs. The production of fully IgG BsAbs is challenging because of the highly heterogeneous pairing of heavy chains (HCs) and light chains (LCs) when produced in mammalian cells with two IgG HCs and two LCs. A solution to the HC heterodimerization aspect of IgG BsAb production was first discovered two decades ago; however, addressing the LC mispairing issue has remained intractable until recently. Here, we use computational and rational engineering to develop novel designs to the HC/LC pairing issue, and particularly for κ LCs. Crystal structures of these designs highlight the interactions that provide HC/LC specificity. We produce and characterize multiple fully IgG BsAbs using these novel designs. We demonstrate the importance of specificity engineering in both the variable and constant domains to achieve robust HC/LC specificity within all the BsAbs. These solutions facilitate the production of fully IgG BsAbs for clinical use.},
doi = {10.1002/pro.3240},
journal = {Protein Science},
number = 10,
volume = 26,
place = {United Kingdom},
year = {Mon Jul 31 00:00:00 EDT 2017},
month = {Mon Jul 31 00:00:00 EDT 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1002/pro.3240

Citation Metrics:
Cited by: 14 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Combined Covalent-Electrostatic Model of Hydrogen Bonding Improves Structure Prediction with Rosetta
journal, January 2015

  • O’Meara, Matthew J.; Leaver-Fay, Andrew; Tyka, Michael D.
  • Journal of Chemical Theory and Computation, Vol. 11, Issue 2
  • DOI: 10.1021/ct500864r

The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells
journal, April 2004


Improving biophysical properties of a bispecific antibody scaffold to aid developability: Quality by molecular design
journal, September 2013

  • Von Kreudenstein, Thomas Spreter; Escobar-Carbrera, Eric; Lario, Paula I.
  • mAbs, Vol. 5, Issue 5
  • DOI: 10.4161/mabs.25632

Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
journal, July 2009

  • Labrijn, Aran F.; Buijsse, Antonio Ortiz; van den Bremer, Ewald T. J.
  • Nature Biotechnology, Vol. 27, Issue 8
  • DOI: 10.1038/nbt.1553

Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects: APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG
journal, April 2010

  • Gunasekaran, Kannan; Pentony, Martin; Shen, Min
  • Journal of Biological Chemistry, Vol. 285, Issue 25
  • DOI: 10.1074/jbc.M110.117382

Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
journal, January 2014

  • Lewis, Steven M.; Wu, Xiufeng; Pustilnik, Anna
  • Nature Biotechnology, Vol. 32, Issue 2
  • DOI: 10.1038/nbt.2797

A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism
journal, January 2015

  • Liu, Zhi; Leng, Esther C.; Gunasekaran, Kannan
  • Journal of Biological Chemistry, Vol. 290, Issue 12
  • DOI: 10.1074/jbc.M114.620260

Computationally Designed Bispecific Antibodies using Negative State Repertoires
journal, April 2016


Suppression of sodium dodecyl sulfate–polyacrylamide gel electrophoresis sample preparation artifacts for analysis of IgG4 half-antibody
journal, June 2006

  • Taylor, Frederick R.; Prentice, Holly L.; Garber, Ellen A.
  • Analytical Biochemistry, Vol. 353, Issue 2
  • DOI: 10.1016/j.ab.2006.02.022

Domain Interactions in the Fab Fragment: A Comparative Evaluation of the Single-chain Fv and Fab Format Engineered with Variable Domains of Different Stability
journal, April 2005

  • Röthlisberger, Daniela; Honegger, Annemarie; Plückthun, Andreas
  • Journal of Molecular Biology, Vol. 347, Issue 4
  • DOI: 10.1016/j.jmb.2005.01.053

An Unfolded CH1 Domain Controls the Assembly and Secretion of IgG Antibodies
journal, June 2009


Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
journal, February 2015

  • Fischer, Nicolas; Elson, Greg; Magistrelli, Giovanni
  • Nature Communications, Vol. 6, Issue 1
  • DOI: 10.1038/ncomms7113

FcRn: the neonatal Fc receptor comes of age
journal, August 2007

  • Roopenian, Derry C.; Akilesh, Shreeram
  • Nature Reviews Immunology, Vol. 7, Issue 9
  • DOI: 10.1038/nri2155

Anchored Design of Protein-Protein Interfaces
journal, June 2011


Bispecific antibodies for cancer therapy: The light at the end of the tunnel?
journal, November 2009


The making of bispecific antibodies
journal, December 2016


Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
journal, October 2007

  • Wu, Chengbin; Ying, Hua; Grinnell, Christine
  • Nature Biotechnology, Vol. 25, Issue 11
  • DOI: 10.1038/nbt1345

‘Knobs-into-holes’ engineering of antibody C H 3 domains for heavy chain heterodimerization
journal, January 1996

  • Ridgway, John B. B.; Presta, Leonard G.; Carter, Paul
  • "Protein Engineering, Design and Selection", Vol. 9, Issue 7
  • DOI: 10.1093/protein/9.7.617

Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies
journal, February 2017

  • Rajendra, Yashas; Peery, Robert B.; Hougland, Maria D.
  • Biotechnology Progress, Vol. 33, Issue 2
  • DOI: 10.1002/btpr.2414

Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
journal, March 2009

  • Michaelson, Jennifer S.; Demarest, Stephen J.; Miller, Brian
  • mAbs, Vol. 1, Issue 2
  • DOI: 10.4161/mabs.1.2.7631

Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
journal, June 2011

  • Schaefer, W.; Regula, J. T.; Bahner, M.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 27
  • DOI: 10.1073/pnas.1019002108

Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization
journal, April 2008


Role of conformational sampling in computing mutation-induced changes in protein structure and stability
journal, December 2010

  • Kellogg, Elizabeth H.; Leaver-Fay, Andrew; Baker, David
  • Proteins: Structure, Function, and Bioinformatics, Vol. 79, Issue 3
  • DOI: 10.1002/prot.22921

Fab-based bispecific antibody formats with robust biophysical properties and biological activity
journal, March 2015


Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence
journal, January 2017

  • Mazor, Yariv; Sachsenmeier, Kris F.; Yang, Chunning
  • Scientific Reports, Vol. 7, Issue 1
  • DOI: 10.1038/srep40098

Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies
journal, November 2012

  • Klein, Christian; Sustmann, Claudio; Thomas, Markus
  • mAbs, Vol. 4, Issue 6
  • DOI: 10.4161/mabs.21379

A Generic Program for Multistate Protein Design
journal, July 2011


Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair
journal, July 2012

  • Strop, Pavel; Ho, Wei-Hsien; Boustany, Leila M.
  • Journal of Molecular Biology, Vol. 420, Issue 3
  • DOI: 10.1016/j.jmb.2012.04.020

Design and production of novel tetravalent bispecific antibodies
journal, February 1997

  • Coloma, M. Josefina; Morrison, Sherie L.
  • Nature Biotechnology, Vol. 15, Issue 2
  • DOI: 10.1038/nbt0297-159

Antiparallel Conformation of Knob and Hole Aglycosylated Half-Antibody Homodimers Is Mediated by a CH2–CH3 Hydrophobic Interaction
journal, May 2014

  • Elliott, J. Michael; Ultsch, Mark; Lee, Joshua
  • Journal of Molecular Biology, Vol. 426, Issue 9
  • DOI: 10.1016/j.jmb.2014.02.015

Protein–Protein Docking with Simultaneous Optimization of Rigid-body Displacement and Side-chain Conformations
journal, August 2003


Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
journal, June 2016

  • Zhukovsky, Eugene A.; Morse, Richard J.; Maus, Marcela V.
  • Current Opinion in Immunology, Vol. 40
  • DOI: 10.1016/j.coi.2016.02.006

Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
journal, March 2013

  • Labrijn, A. F.; Meesters, J. I.; de Goeij, B. E. C. G.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 13
  • DOI: 10.1073/pnas.1220145110

Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
journal, October 2016


Alternate States of Proteins Revealed by Detailed Energy Landscape Mapping
journal, January 2011

  • Tyka, Michael D.; Keedy, Daniel A.; André, Ingemar
  • Journal of Molecular Biology, Vol. 405, Issue 2
  • DOI: 10.1016/j.jmb.2010.11.008

Improving target cell specificity using a novel monovalent bispecific IgG design
journal, January 2015


Transcriptional and post-transcriptional targeting for enhanced transient gene expression in CHO cells
journal, August 2015

  • Rajendra, Yashas; Hougland, Maria D.; Schmitt, Matthew G.
  • Biotechnology Letters, Vol. 37, Issue 12
  • DOI: 10.1007/s10529-015-1938-6

Alternative molecular formats and therapeutic applications for bispecific antibodies
journal, October 2015


Despite slow progress, bispecifics generate buzz
journal, December 2016


Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
journal, July 2013

  • Spiess, Christoph; Merchant, Mark; Huang, Arthur
  • Nature Biotechnology, Vol. 31, Issue 8
  • DOI: 10.1038/nbt.2621

Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor
journal, February 2015

  • Papadopoulos, Kyriakos P.; Isaacs, Randi; Bilic, Sanela
  • Cancer Chemotherapy and Pharmacology, Vol. 75, Issue 5
  • DOI: 10.1007/s00280-015-2712-0

Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules
journal, December 2009

  • Jordan, Jacob L.; Arndt, Joseph W.; Hanf, Karl
  • Proteins: Structure, Function, and Bioinformatics, Vol. 77, Issue 4
  • DOI: 10.1002/prot.22502

Enhanced plasmid DNA utilization in transiently transfected CHO-DG44 cells in the presence of polar solvents
journal, August 2015

  • Rajendra, Yashas; Balasubramanian, Sowmya; Kiseljak, Divor
  • Biotechnology Progress, Vol. 31, Issue 6
  • DOI: 10.1002/btpr.2152

Comparing domain interactions within antibody Fabs with kappa and lambda light chains
journal, July 2016


Bispecific antibodies
journal, July 2015


Targeting T Cells with Bispecific Antibodies for Cancer Therapy
journal, January 2011